Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population
ConclusionLong-term cardiovascular disease outcomes differed across the MAFLD subtypes. Further studies are required to investigate whether preventive or therapeutic interventions should be optimized according to the MAFLD subtypes.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Heart | Heart Attack | Heart Failure | Infectious Diseases | Ischemic Stroke | Liver | Liver Disease | Obesity | Stroke | Study | Urology & Nephrology